"Protocol for a phase 2, randomized, double-blind, placebo-controlled, safety and efficacy study of dutogliptin in combination with filgrastim in early recovery post-myocardial infarction": study protocol for a randomized controlled trial.

MLA

von Lewinski, Dirk, et al. “‘Protocol for a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction’: Study Protocol for a Randomized Controlled Trial.” Trials, vol. 21, no. 1, Aug. 2020, p. 744. EBSCOhost, https://doi.org/10.1186/s13063-020-04652-0.

APA

von Lewinski, D., Selvanayagam, J. B., Schatz, R. A., Jilma, B., Kubica, J., Povsic, T. J., Nix, D., Henauer, S., & Wallner, M. (2020). “Protocol for a phase 2, randomized, double-blind, placebo-controlled, safety and efficacy study of dutogliptin in combination with filgrastim in early recovery post-myocardial infarction”: study protocol for a randomized controlled trial. Trials, 21(1), 744. https://doi.org/10.1186/s13063-020-04652-0

Chicago

von Lewinski, Dirk, Joseph B Selvanayagam, Richard A Schatz, Bernd Jilma, Jacek Kubica, Thomas J Povsic, Darrell Nix, Stephan Henauer, and Markus Wallner. 2020. “‘Protocol for a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction’: Study Protocol for a Randomized Controlled Trial.” Trials 21 (1): 744. doi:10.1186/s13063-020-04652-0.